Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Imprimis Pharmaceuticals, Inc. (IMMY)

-NasdaqCM
7.28 0.05(0.69%) Apr 23, 3:59PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 3   3   3   3  
Cost of Revenue -   -   -   -  
Gross Profit 3   3   3   3  
Operating Expenses
Research Development14  469  677  455  
Selling General and Administrative1,882  1,623  1,556  1,020  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,893) (2,090) (2,231) (1,473)
Income from Continuing Operations
Total Other Income/Expenses Net11  12  13  7  
Earnings Before Interest And Taxes(1,882)(2,077)(2,218)(1,465)
Interest Expense -   -   -   -  
Income Before Tax(1,882)(2,077)(2,218)(1,465)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,882)(2,077)(2,218)(1,465)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,882) (2,077) (2,218) (1,465)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,882) (2,077) (2,218) (1,465)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.